- Delta 9 Cannabis (DN) provides guidance on its revenue forecast for the three-month period ended March 31, 2022 based on preliminary results
- The Company anticipates revenue for the three-month period to be between $12.4 million and $12.6 million compared with $13.2 million for the same period last year
- A news release on the financials will be issued on May 16, 2022, before the stock market opens
- Delta 9 Cannabis Inc. is a vertically integrated cannabis company focused on bringing the highest quality cannabis products to market
- Delta 9 Cannabis Inc. (DN) was up 6.38 per cent, trading at C$0.25 per share at 12:43 pm ET
Delta 9 Cannabis (DN) has provided guidance on its revenue forecast for the three-month period ended March 31, 2022.
The company anticipates revenue for the three-month period to be between $12.4 million and $12.6 million compared with $13.2 million for the same period last year.
Delta 9 will provide investors with a full breakdown of revenue and financial results as part of its Financial Statements and Management Discussion and Analysis for the three-month period ending March 31, 2022.
A news release on the financials will be issued on May 16, 2022, before the stock market opens. This will be followed by a conference call the same day at 12:00 p.m. EDT.
The preliminary estimated revenues for the three-month period are subject to the completion of the company’s financial closing procedures. These preliminary estimated financial results have been prepared by and are the responsibility of the company’s management.
The company currently expects its final results for revenue to be consistent with the estimates released. However, such estimates are preliminary, and the Company’s actual results of operations and other data could differ materially from these estimates due to the completion of its financial closing procedures, final adjustments and other developments that may arise between now and the time such consolidated financial statements for the period ended March 31, 2022, are issued.
Delta 9 Cannabis Inc. is a cannabis company focused on bringing quality cannabis products to market. The company sells cannabis products through its wholesale and retail sales channels and sells its cannabis grow pods to other businesses.
Delta 9’s wholly-owned subsidiary, Delta 9 Bio-Tech Inc., is a licensed producer of medical and recreational cannabis and operates an 80,000 square foot production facility in Winnipeg, Manitoba, Canada. Delta 9 owns and operates a chain of retail stores under the Delta 9 Cannabis Store brand.
Delta 9 Cannabis Inc. (DN) was up 6.38 per cent, trading at C$0.25 per share at 12:43 pm ET.
